Man Group PLC Veracyte, Inc. Transaction History

Man Group PLC

$49.7 Billion
Q2 2025

A detailed history of Man Group PLC transactions in Veracyte, Inc. stock. As of the latest transaction made, Man Group PLC holds 126,571 shares of VCYT stock, worth $4.56 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

126,571

Previous 84,167 50.38%

Holding current value

$4.56 Million

Previous $2.5 Million 37.11%

% of portfolio

0.01%

Previous 0.01%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$26.39 - $32.62 $1.12 Million - $1.38 Million	42,404 Added 50.38%	126,571 $3.42 Million
Q1 2025 May 15, 2025	SELL	$29.65 - $46.14 $1.11 Million - $1.73 Million	-37,578 Reduced 30.87%	84,167 $2.5 Million
Q4 2024 Feb 14, 2025	SELL	$31.92 - $44.4 $9.39 Million - $13.1 Million	-294,029 Reduced 70.72%	121,745 $4.82 Million
Q3 2024 Nov 14, 2024	SELL	$21.0 - $35.25 $5.53 Million - $9.29 Million	-263,524 Reduced 38.79%	415,774 $14.1 Million
Q2 2024 Aug 14, 2024	BUY	$18.86 - $23.55 $3.94 Million - $4.91 Million	208,650 Added 44.33%	679,298 $14.7 Million
Q1 2024 May 15, 2024	BUY	$21.0 - $29.1 $812,826 - $1.13 Million	38,706 Added 8.96%	470,648 $10.4 Million
Q4 2023 Feb 14, 2024	BUY	$19.72 - $28.68 $4.18 Million - $6.08 Million	211,889 Added 96.29%	431,942 $11.9 Million
Q3 2023 Nov 14, 2023	BUY	$22.33 - $29.92 $3.56 Million - $4.77 Million	159,431 Added 262.99%	220,053 $4.91 Million
Q2 2023 Aug 14, 2023	BUY	$20.96 - $26.99 $1.27 Million - $1.64 Million	60,622 New	60,622 $1.54 Million
Q3 2022 Nov 14, 2022	SELL	$16.58 - $27.9 $137,630 - $231,597	-8,301 Reduced 19.02%	35,334 $587,000
Q2 2022 Aug 15, 2022	SELL	$15.45 - $29.52 $1.99 Million - $3.8 Million	-128,774 Reduced 74.69%	43,635 $869,000
Q1 2022 May 16, 2022	BUY	$21.94 - $42.51 $3.78 Million - $7.33 Million	172,409 New	172,409 $4.75 Million
Q3 2021 Nov 15, 2021	SELL	$35.62 - $52.97 $423,877 - $630,343	-11,900 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$32.94 - $56.62 $98,820 - $169,860	3,000 Added 33.71%	11,900 $476,000
Q1 2021 May 17, 2021	SELL	$44.47 - $81.38 $65,548 - $119,954	-1,474 Reduced 14.21%	8,900 $478,000
Q4 2020 Feb 16, 2021	BUY	$32.49 - $61.88 $337,051 - $641,943	10,374 New	10,374 $508,000

Others Institutions Holding VCYT

# of Institutions

295

Shares Held

77.2M

Call Options Held

Put Options Held

17.6K

View Full List

About VERACYTE, INC.

Ticker VCYT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,575,904
Market Cap $2.58B
Description
Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...

More about VCYT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Man Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Man Group PLC with notifications on news.

Account